Annual EBITDA
$20.04 M
+$3.74 M+22.93%
December 31, 2023
Summary
- As of February 8, 2025, IRMD annual EBITDA is $20.04 million, with the most recent change of +$3.74 million (+22.93%) on December 31, 2023.
- During the last 3 years, IRMD annual EBITDA has risen by +$19.45 million (+3338.39%).
- IRMD annual EBITDA is now at all-time high.
Performance
IRMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$5.99 M
+$160.50 K+2.75%
September 30, 2024
Summary
- As of February 8, 2025, IRMD quarterly EBITDA is $5.99 million, with the most recent change of +$160.50 thousand (+2.75%) on September 30, 2024.
- Over the past year, IRMD quarterly EBITDA has increased by +$160.50 thousand (+2.75%).
- IRMD quarterly EBITDA is now -1.78% below its all-time high of $6.10 million, reached on September 30, 2023.
Performance
IRMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$22.15 M
-$108.50 K-0.49%
September 30, 2024
Summary
- As of February 8, 2025, IRMD TTM EBITDA is $22.15 million, with the most recent change of -$108.50 thousand (-0.49%) on September 30, 2024.
- Over the past year, IRMD TTM EBITDA has dropped by -$108.50 thousand (-0.49%).
- IRMD TTM EBITDA is now -0.49% below its all-time high of $22.26 million, reached on June 30, 2024.
Performance
IRMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IRMD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.9% | +2.8% | -0.5% |
| 3 y3 years | +3338.4% | +2.8% | -0.5% |
| 5 y5 years | +181.8% | +2.8% | -0.5% |
IRMD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.5% | -1.8% | +71.2% | -0.5% | +97.4% |
| 5 y | 5-year | at high | +3338.4% | -1.8% | +329.8% | -0.5% | +3702.3% |
| alltime | all time | at high | +3338.4% | -1.8% | +329.8% | -0.5% | +3702.3% |
IRadimed EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.99 M(+2.8%) | $22.15 M(-0.5%) |
| Jun 2024 | - | $5.83 M(+17.1%) | $22.26 M(+3.1%) |
| Mar 2024 | - | $4.97 M(-7.3%) | $21.59 M(+3.8%) |
| Dec 2023 | $20.04 M(+22.9%) | $5.37 M(-12.0%) | $20.80 M(+5.6%) |
| Sep 2023 | - | $6.10 M(+18.3%) | $19.69 M(+8.4%) |
| Jun 2023 | - | $5.15 M(+22.9%) | $18.16 M(+2.8%) |
| Mar 2023 | - | $4.19 M(-1.5%) | $17.67 M(+4.0%) |
| Dec 2022 | $16.30 M(+45.2%) | $4.25 M(-6.9%) | $16.99 M(+4.7%) |
| Sep 2022 | - | $4.57 M(-2.0%) | $16.23 M(+7.6%) |
| Jun 2022 | - | $4.66 M(+32.8%) | $15.09 M(+19.6%) |
| Mar 2022 | - | $3.51 M(+0.4%) | $12.62 M(+12.5%) |
| Dec 2021 | $11.22 M(+1826.3%) | $3.50 M(+2.0%) | $11.22 M(+28.7%) |
| Sep 2021 | - | $3.43 M(+56.3%) | $8.72 M(+36.1%) |
| Jun 2021 | - | $2.19 M(+4.0%) | $6.41 M(+298.1%) |
| Mar 2021 | - | $2.11 M(+113.0%) | $1.61 M(+176.2%) |
| Dec 2020 | $582.70 K(-94.1%) | $990.00 K(-11.3%) | $582.60 K(-72.4%) |
| Sep 2020 | - | $1.12 M(-142.8%) | $2.11 M(-44.5%) |
| Jun 2020 | - | -$2.61 M(-340.8%) | $3.80 M(-58.1%) |
| Mar 2020 | - | $1.08 M(-57.1%) | $9.07 M(-8.3%) |
| Dec 2019 | $9.89 M(+39.1%) | $2.52 M(-10.3%) | $9.89 M(+5.0%) |
| Sep 2019 | - | $2.81 M(+5.5%) | $9.42 M(+16.6%) |
| Jun 2019 | - | $2.66 M(+40.0%) | $8.08 M(+7.8%) |
| Mar 2019 | - | $1.90 M(-7.4%) | $7.49 M(+5.4%) |
| Dec 2018 | $7.11 M | $2.05 M(+40.3%) | $7.11 M(+11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $1.46 M(-29.6%) | $6.39 M(+17.0%) |
| Jun 2018 | - | $2.08 M(+37.1%) | $5.46 M(+34.6%) |
| Mar 2018 | - | $1.52 M(+13.3%) | $4.06 M(+56.5%) |
| Dec 2017 | $2.59 M(-78.2%) | $1.34 M(+150.5%) | $2.59 M(-13.7%) |
| Sep 2017 | - | $534.00 K(-20.7%) | $3.01 M(-46.8%) |
| Jun 2017 | - | $673.30 K(+1282.5%) | $5.65 M(-32.6%) |
| Mar 2017 | - | $48.70 K(-97.2%) | $8.38 M(-29.4%) |
| Dec 2016 | $11.88 M(-3.6%) | $1.75 M(-44.9%) | $11.88 M(-15.9%) |
| Sep 2016 | - | $3.18 M(-6.5%) | $14.12 M(-0.6%) |
| Jun 2016 | - | $3.40 M(-4.0%) | $14.20 M(+4.8%) |
| Mar 2016 | - | $3.54 M(-11.3%) | $13.55 M(+10.0%) |
| Dec 2015 | $12.32 M(+283.2%) | $4.00 M(+22.6%) | $12.32 M(+43.3%) |
| Sep 2015 | - | $3.26 M(+18.6%) | $8.60 M(+48.5%) |
| Jun 2015 | - | $2.75 M(+18.7%) | $5.79 M(+23.6%) |
| Mar 2015 | - | $2.32 M(+742.7%) | $4.69 M(+45.8%) |
| Dec 2014 | $3.21 M(+9.9%) | $274.80 K(-39.1%) | $3.21 M(-13.2%) |
| Sep 2014 | - | $451.50 K(-72.5%) | $3.70 M(+1.7%) |
| Jun 2014 | - | $1.64 M(+94.6%) | $3.64 M(+29.6%) |
| Mar 2014 | - | $844.90 K(+10.6%) | $2.81 M(-4.0%) |
| Dec 2013 | $2.93 M(+91.1%) | $763.90 K(+96.6%) | $2.93 M(+35.3%) |
| Sep 2013 | - | $388.60 K(-52.2%) | $2.16 M(+21.9%) |
| Jun 2013 | - | $812.90 K(-15.4%) | $1.77 M(+84.6%) |
| Mar 2013 | - | $960.80 K | $960.80 K |
| Dec 2012 | $1.53 M | - | - |
FAQ
- What is IRadimed annual EBITDA?
- What is the all time high annual EBITDA for IRadimed?
- What is IRadimed annual EBITDA year-on-year change?
- What is IRadimed quarterly EBITDA?
- What is the all time high quarterly EBITDA for IRadimed?
- What is IRadimed quarterly EBITDA year-on-year change?
- What is IRadimed TTM EBITDA?
- What is the all time high TTM EBITDA for IRadimed?
- What is IRadimed TTM EBITDA year-on-year change?
What is IRadimed annual EBITDA?
The current annual EBITDA of IRMD is $20.04 M
What is the all time high annual EBITDA for IRadimed?
IRadimed all-time high annual EBITDA is $20.04 M
What is IRadimed annual EBITDA year-on-year change?
Over the past year, IRMD annual EBITDA has changed by +$3.74 M (+22.93%)
What is IRadimed quarterly EBITDA?
The current quarterly EBITDA of IRMD is $5.99 M
What is the all time high quarterly EBITDA for IRadimed?
IRadimed all-time high quarterly EBITDA is $6.10 M
What is IRadimed quarterly EBITDA year-on-year change?
Over the past year, IRMD quarterly EBITDA has changed by +$160.50 K (+2.75%)
What is IRadimed TTM EBITDA?
The current TTM EBITDA of IRMD is $22.15 M
What is the all time high TTM EBITDA for IRadimed?
IRadimed all-time high TTM EBITDA is $22.26 M
What is IRadimed TTM EBITDA year-on-year change?
Over the past year, IRMD TTM EBITDA has changed by -$108.50 K (-0.49%)